Last reviewed: May 23, 2026

Last updated: May 23, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Ozempic (semaglutide) is FDA-approved for type 2 diabetes management but is prescribed off-label for weight loss in non-diabetic patients. Clinical data shows GLP-1 receptor agonists reduce appetite and body weight by 10-15% in many patients, though individual responses vary significantly based on metabolic factors and genetic predispositions.

If you're considering GLP-1 therapy for weight loss, understanding medical eligibility, mechanism of action, and how your individual biomarkers may relate to treatment response can help guide a more informed discussion with your healthcare provider. PlexusDx supports this precision-wellness approach by combining clinical evidence with personalized biomarker insights.

How Ozempic Works for Weight Loss: Mechanism and Clinical Evidence

Semaglutide mimics glucagon-like peptide-1 (GLP-1), a hormone regulating appetite, satiety, and blood sugar. In clinical trials, patients on semaglutide experienced reduced hunger signals, delayed gastric emptying, and improved appetite control. The STEP trials demonstrated weight loss of 10-22% over 68 weeks depending on dosing and individual factors.

Off-label use in non-diabetic patients is common, though it remains an FDA-approved indication only for type 2 diabetes and chronic weight management. Off-label prescribing is legal and medically supported by evidence, but availability depends on provider discretion and insurance coverage eligibility criteria.

Medical Eligibility and Provider Requirements for GLP-1 Therapy

Not all patients qualify for semaglutide or other GLP-1 medications. Providers typically evaluate BMI, weight-related comorbidities (hypertension, prediabetes, sleep apnea), medical history, and contraindications before prescribing. A comprehensive provider evaluation is essential before starting treatment.

Common eligibility criteria include BMI ≥30 (or ≥27 with weight-related conditions), absence of thyroid cancer history or medullary thyroid carcinoma family history, and stable mental health. Pregnancy, breastfeeding, and certain gastrointestinal conditions may contraindicate use.

Eligibility Factor Typical Consideration
Body Mass Index (BMI) ≥30 kg/m², or ≥27 with comorbidities
Weight-Related Conditions Hypertension, prediabetes, PCOS, sleep apnea support eligibility
Thyroid and Cancer History Personal/family history of medullary thyroid cancer is contraindication
Cardiovascular Status Stable cardiac function; provider clearance if significant disease present
Gastrointestinal Health History of pancreatitis or severe GI disease requires careful evaluation

Biomarkers and Genetic Factors That May Influence GLP-1 Response

Individual response to GLP-1 therapy varies widely. Metabolic markers (fasting glucose, insulin resistance, HbA1c) and inflammatory markers can provide context for treatment suitability. Genetic variants in GLP-1 receptor pathways, appetite-regulation genes, and obesity-susceptibility loci may influence how effectively a patient responds to therapy.

Research suggests specific genetic variants—such as GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313—predispose individuals toward different metabolic phenotypes and appetite regulation patterns. While these variants do not predict exact medication response, they may help providers understand underlying biology and personalize dosing or monitoring strategies.

Accessing GLP-1 Treatment: Branded vs. Compounded Options and Safety Considerations

Ozempic and Wegovy (branded semaglutide) are available through traditional pharmacies with insurance or out-of-pocket payment, though shortages and cost barriers are common. Compounded semaglutide offers a regulated alternative from licensed 503A compounding pharmacies at lower cost, typically $149 monthly versus $900–$1,300 for branded formulations.

All GLP-1 therapy carries potential side effects including nausea, constipation, pancreatitis risk (rare), and thyroid concerns; require ongoing provider monitoring. Before starting any GLP-1 medication, discuss medical history, current medications, and monitoring plans with your healthcare provider to ensure safety and appropriate dosing.

How PlexusDx Supports a More Personalized Approach

PlexusDx's Precision Peptide Genetic Test may help provide context about your genetic predispositions in GLP-1 receptor pathways and appetite-regulation genes. The test reveals variants such as GLP1R rs6923761, GIPR rs1800437, FTO rs9939609, and MC4R rs17782313—markers associated with differences in metabolic response and appetite control. This information should be interpreted with a qualified healthcare provider as part of a broader clinical evaluation.

The genetic test does not predict whether you will or will not respond to GLP-1 therapy; rather, it identifies predispositions in peptide-related genetic pathways that may inform personalized discussion with your provider. Combined with your medical history, biomarkers, and clinical presentation, these insights can support a more tailored treatment approach.

PlexusDx compounded semaglutide ($149/mo) and other GLP-1 options from licensed 503A pharmacies provide regulated alternatives for eligible patients. Whether you choose branded Ozempic, compounded semaglutide, or tirzepatide, understanding your genetic and metabolic context can support a more informed conversation with your provider about which option aligns with your clinical needs and goals.

How Your Genetics Influence GLP-1 Response

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Tirzepatide Injection starts at $249/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.

Related Reading

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.

Real prescribers. Published prices. No surprises.

Licensed providers in all 50 states. Online intake. No insurance, no membership required.

Start My Intake →

~60 seconds · $0 charged until your provider approves